New eye drops aim to boost blood flow in diabetic retinopathy and glaucoma
NCT ID NCT07354477
First seen Jan 26, 2026 · Last updated May 23, 2026 · Updated 19 times
Summary
This study tests an eye drop called QLS-111 in 14 people with diabetic retinopathy or certain types of glaucoma. The goal is to see if it can improve blood flow to the back of the eye. Participants will receive the drops and have their eyes imaged over several weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPEN ANGLE GLAUCOMA (OAG) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University, Dept. of Ophthalmology
RECRUITINGPalo Alto, California, 94303, United States
Conditions
Explore the condition pages connected to this study.